Prenatal exposures to alcohol (PAE) and tobacco (PTE) are known to produce adverse neonatal and childhood outcomes including damage to the developing auditory system. Knowledge of the timing, extent, and combinations of these exposures on effects on the developing system is limited. As part of the physiological measurements from the Safe Passage Study, Auditory Brainstem Responses (ABRs) and Transient Otoacoustic Emissions (TEOAEs) were acquired on infants at birth and one-month of age. Research sites were in South Africa and the Northern Plains of the U.S. Prenatal information on alcohol and tobacco exposure was gathered prospectively on mother/infant dyads. Cluster analysis was used to characterize three levels of PAE and three levels of PTE. Repeated-measures ANOVAs were conducted for newborn and one-month-old infants for ABR peak latencies and amplitudes and TEOAE levels and signal-to-noise ratios. Analyses controlled for hours of life at test, gestational age at birth, sex, site, and other exposure. Significant main effects of PTE included reduced newborn ABR latencies from both ears. PTE also resulted in a significant reduction of ABR peak amplitudes elicited in infants at 1-month of age. PAE led to a reduction of TEOAE amplitude for 1-month-old infants but only in the left ear. Results indicate that PAE and PTE lead to early disruption of peripheral, brainstem, and cortical development and neuronal pathways of the auditory system, including the olivocochlear pathway.

The purpose of this study was to determine the effects of prenatal alcohol exposure (PAE), prenatal tobacco exposure (PTE), and the combination of the two on the developing auditory system of human infants. Two objective measures used as biomarkers of auditory system function were employed. The speed and objectivity of the auditory brainstem response (ABR) [1, 2] and the transient otoacoustic emission (TEOAE) [3, 4] have established these tests as diagnostic and scientific measures of auditory system function in newborns. The measures as applied in this study have been described previously [5].

ABR is a sound-evoked, averaged neural potential, differentially recorded from surface electrodes in response to transient sounds. The surface-recorded ABR was first described by Jewett and colleagues [6] 50 years ago. ABR generators are the auditory nerve and the low brainstem auditory pathway [7, 8]. The morphology of the response from newborns is comprised of 3 of the 5 peaks seen in the mature response. ABR can be used to characterize the temporal aspects of neural transmission through the brainstem pathway when elicited by high-level (60–80 dB above hearing threshold), transient, click stimuli [2].

The TEOAE first described by Kemp [9] is reflected energy from the cochlear amplifier of the outer hair cells (OHCs). The stimulus is presented via an ear canal probe device with a transducer to deliver sound to the tympanic membrane. The sound pressure is transmitted through the middle ear and into the cochlear fluids. This motion activates the inner hair cells (IHCs) and OHCs of the cochlea. The action of the OHC is a motor-like response, physically expanding and contracting the cells. The hair cells are firmly attached to the basilar membrane and therefore the OHC-transmitted motion increases the sensitivity of the IHC by as much as 20–60 dB and dramatically sharpens the tuning, thus the term cochlear amplifier [10]. Some of this additional energy from the OHC travels back along the incoming sound path and creates a pressure waveform in the ear canal (otoacoustic emission) that is measured with a sensitive microphone in the OAE probe.

The presence of a TEOAE provides an objective measure of cochlear function, specifically OHC presence and motility. The motor process of the OHC requires no neural input. However, the TEOAE is modulated (inhibited) by activation of brainstem medial olivocochlear (MOC) efferent neurons that synapse on the OHC [11].

The TEOAE and ABR are both objective measures that are well suited to infant evaluations but provide distinct information about the auditory system. They are not used in this application to determine hearing levels, rather cochlear (TEOAE) and brainstem (ABR) function. The TEOAE can also be an indirect measure of efferent activity from the brainstem.

Prenatal Exposures

Prenatal exposure to cigarette smoking and alcohol is known to inflict damage on the developing human auditory system [12-14]. Both nicotine and alcohol are found in the fetal blood supply after passing through the placenta where they can have significant toxic effects on many aspects of cell development [15]. However, prior studies have not clearly identified the degree of in utero exposure associated with damage nor the extent of such damage to the developing human auditory system.

Exposure to Smoking

Fetal morbidities related to PTE include reduced birth weight, decreased head circumference, hypoxia, and alteration in fetal blood flow and protein metabolism [13-18]. Both prenatal [19] and environmental exposure [17, 20] to tobacco smoke have been clearly linked to increased incidence of otitis media in infants and children. One study documented that PTE results in slightly increased levels of high-frequency hearing loss and a greater percentage of unilateral hearing loss in adolescents [21]. However, no evidence of peripheral hearing loss in infants or young children following PTE has been published. Neurodevelopmental disorders are also associated with PTE [13, 14], many of which are related to auditory system function. In particular, children born with PTE have been found to show lower scores on measures of cognitive function and developmental skills [18, 22], memory [23, 24], verbal subscales of intelligence tests [24-26], and reading and phonological processing [27]. Difficulty with tasks involving auditory processing is repeatedly mentioned in children with PTE [18, 28-32]. McCartney et al. [33] found reduced performance of 6- to 11-year-old children on the SCAN test, which evaluates central auditory processing skills. Performance from the children with PTE was particularly poor on the test section involving identification of dichotic competing words. Clearly, children with PTE are at risk for auditory difficulties that can be subtle and may not involve peripheral hearing loss.

Auditory system evaluations have been previously used to assess outcomes of PTE. Kable and colleagues [34] found that the PTE level was negatively related to wave V latency and waves I–V interpeak latency intervals in 6-month-old infants. Katbamna et al. [35] compared full-term, otherwise healthy infants from a group of mothers who smoked to a control group born to nonsmoking mothers using ABRs and distortion-product otoacoustic emissions (DPOAEs). DPOAE amplitudes were reduced in the infants with PTE. The latency of ABR peak V and the interpeak interval I–V was also reduced in the exposed infants relative to controls. Korres et al. [36] enrolled pregnant women at the time of birth who were grouped as nonsmokers, and low-, moderate-, or high-level smokers based on history. Binaural TEOAEs were smaller for the PTE group, but TEOAE levels did not change with smoking group. Durante et al. [37] compared neonates of nonsmoking mothers to infants of mothers who smoked >5 cigarettes per day. The infants with PTE demonstrated reduced amplitude TEOAEs relative to controls in the right ear only. Neither TEOAEs in the left ear nor DPOAEs in either ear distinguished the groups.

Exposure to Alcohol

Prenatal alcohol exposure may result in fetal alcohol spectrum disorder (FASD) with fetal alcohol syndrome (FAS) being the most severe condition in the spectrum. PAE can lead to oxidative injury, apoptosis, gene expression modulation, and disruption of neuronal migration, which is reflected in central nervous system dysfunction, growth deficiencies, characteristic facial abnormalities, and other malformations [38, 39]. Abnormal functioning in the areas of cognition, executive function, memory, language, adaptive functioning, auditory and visual perception, and academic performance has been described in persons with FASD [39-41]. Neuroimaging and autopsy studies of FASD and PAE have universally found evidence of reduced brain volume in response to the exposure [42-49]. Specific abnormalities in brain structure including cortical development, white matter microstructure, and functional connectivity have been associated with PAE [39].

Auditory system dysfunction is often distinguished in association with PAE although hearing loss, as defined by elevated hearing thresholds due to middle ear or cochlear dysfunction, has only been described in children with FAS. One study of visual and auditory attention compared adults with FASD to typically functioning, age-matched adults and found that the participants with alcohol exposure had more difficulty with auditory stimuli than visual on the attention task [50]. Behavioral assessments of “Central Auditory Processing” abilities have also uncovered dysfunction in children with FASD including abnormal speech perception in noise [51] and reduced incidence of the expected “right ear advantage” on dichotic speech perception tests [52].

There have been no systematic studies of ABR results on human infants or children with PAE without FASD. One study of ABR in children with FAS [53] found a high prevalence of hearing loss, which would contaminate the evaluation of ABR peak latencies and amplitudes. Standard cortical event-related potentials [54, 55] and magnetoencephalography [56] event-related potentials have found that children with PAE demonstrate abnormally long peak latencies and reduced peak amplitudes. These findings are indicative of poor processing of auditory signals at the level of the auditory cortex. At present, otoacoustic emission testing has not been applied to the study of PAE.

Prenatal Alcohol and Tobacco Interactions

Auditory system outcomes, as with other neurodevelopmental outcomes [57], may be influenced by interactions between the effects of prenatal alcohol and tobacco. Kable et al. [34], when evaluating PTE effects on ABR, also found that alcohol use was related to ABR latency. Unfortunately, other evaluations of auditory system outcomes either eliminated maternal subjects with a history of the other exposure [35, 37] or did not include the other substance use in maternal assessments [36, 54, 55, 58]. Therefore, little is known about how interactions of these prenatal exposures may influence auditory system outcome.

The current study reports findings from the safe passage study, a large, international, prospective, and multidisciplinary investigation designed to examine the role of PAE and PTE in association with sudden infant death syndrome (SIDS), stillbirth, and to determine physiological outcomes from exposures in surviving children [59]. In the full study, 10,727 infants were followed for 1 year [60].

This study had the advantage of extensive prospective documentation of exposures. Other studies of ABR or TEOAE following prenatal exposures enrolled mothers at the time of birth with retrospective documentation of smoking and drinking behavior [34-37]. The limitations of historical data collection are well known. Jacobson et al. [61] studied antenatal and retrospective reporting of alcohol, smoking, and cocaine use in pregnant women and demonstrated that the antenatal interview provided the most valid information. The data presented here represent the largest database and only prospective study of serial ABRs, and TEOAEs with documented PTE and PAE available to date. The sample size, the diversity of the participants, and the extensive prenatal data collection afford a more complete representation of the PAE and PTE results. The physiologic auditory system outcomes are described here.

Participants

Participants in this study were enrolled in the safe passage study [59], a multidisciplinary, prospective study designed primarily to investigate the relationship between prenatal alcohol exposure and SIDS [60] and stillbirth. Mother-infant dyads were enrolled at 2 regional centers, the Northern Plains of the USA and South Africa. Institutional Review Board approvals were obtained from sponsoring organizations at the participating clinical sites, as well as for the Data Coordinating Center and the Physiological Assessment Center [59, 62]. Newborn and 1-month visits were conducted in North and South Dakota from 5 sites, including 2 Native American Reservations, and in Cape Town, South Africa (Tygerberg and Karl Bremer hospitals). Sites were selected for high rates of prenatal alcohol use and SIDS. In addition, these populations represent diverse communities who exemplify one culture or multiple cultures and socioeconomic status. The Dakota sites are grouped to form the Northern Plains (NP) Center and South Africa (SA) forms the second Center.

Extensive pre- and postnatal documentation and assessments of the mothers and infants were conducted including, but not limited to, exposures to alcohol and cigarette smoking. Data collected included demographics, medical and obstetric records, and information on dietary and psychosocial history including depression, resilience, traumatic and threatening experiences, anxiety, and perceived stress. Self-reported exposure (e.g., alcohol, tobacco, marijuana, and methamphetamines) and fetal physiological measurements were obtained approximately every 8 weeks during the prenatal period. Summaries of enrollment and exposure assessments have been previously published [59, 60].

Newborn participant demographics for infants in this study including gestational age (GA) at birth, hours of life at test, GA at test, delivery type, sex, and race/ethnicity are shown in Table 1. Table 2 includes exposure levels for alcohol and smoking clusters by trimester. Table 3 includes a cross-tabulation of cluster membership for participants by evaluation type. Across ages and assessments, 31.2% of subjects had no exposure, 16% were exposed to tobacco alone, 24.5% were exposed to alcohol alone, and 27.3% were exposed to both alcohol and tobacco.

Table 1.

Descriptive statistics based on newborn ABR tests

Descriptive statistics based on newborn ABR tests
Descriptive statistics based on newborn ABR tests
Table 2.

Mean and interquartile range of exposures for alcohol and smoking clusters per trimester

Mean and interquartile range of exposures for alcohol and smoking clusters per trimester
Mean and interquartile range of exposures for alcohol and smoking clusters per trimester
Table 3.

Cross-tabulation of participants included in the final data analysis by alcohol and smoking clusters for each assessment

Cross-tabulation of participants included in the final data analysis by alcohol and smoking clusters for each assessment
Cross-tabulation of participants included in the final data analysis by alcohol and smoking clusters for each assessment

Auditory system data were collected between April 2009 and August 2015. ABRs were performed on 3,892 newborns (1,567 from NP and 2,325 from SA) and again on 1,092 infants at 1 month of age (402 from NP and 690 from SA). Preterm infants were included in the analysis, and the GA at birth was used as a covariate. Data for the final ABR analysis were missing or excluded on 733 due to technical errors or uninterpretable recordings. Participant’s data were also excluded from the analysis based on the prenatal exposure to psychiatric medications at any point in pregnancy (SSRIs, antidepressants, anxiolytics, antipsychotics, mood stabilizers, stimulants, and anticonvulsants) or early infant demise. The final analysis was conducted on 2,613 newborn and 925 1-month ABRs.

TEOAEs were recorded from 2,250 newborns (825 from NP and 1,425 from SA) and 2,227 infants at 1 month of age (1,058 from NP and 1,389 from SA). TEOAEs that did not meet a criterion signal-to-noise ratio (SNR) of 4 dB in 4 of the 6 frequency bands were removed from analyses due to possible contamination from common infant middle ear conditions [5]. The final number of participants providing TEOAE data for analysis was 1,928 newborn and 1,973 1-month TEOAEs.

Exposure Measures

Cluster analyses used to characterize levels of PAE and PTE into subcategories were based on timing, duration, and amount of exposure as previously described [63, 64]. Two of the original 4 PASS alcohol clusters were collapsed for this study to create a 3-level PAE variable. The “Low Continuous” and “High or Moderate Continuous” clusters [52] were combined into 1 cluster termed “Continuous.” The final PAE clusters included “Unexposed,” “Quit Early,” and “Continuous.” The clusters used for PTE included “Unexposed,” “Low Continuous and Quit Early” (LCQE), and “High and Moderate Continuous” (HMC). The data for each exposure and cluster by trimester can be found in Table 2. The cross-tabulation of participants by smoking and alcohol clusters for each experimental group is shown in Table 3. Overall, 31.2% of mothers used neither alcohol nor tobacco, 16% smoked but did not drink alcohol, 25.5% drank alcohol but did not smoke, and 27.3% used both tobacco and alcohol.

ABR and TEOAE Measurements

Complete details of ABR and TEOAE procedures used in this study have been published [5]. ABRs were measured with Intelligent Hearing Systems USBLite hardware in response to 80 dB nHL clicks and TEOAEs were measured on an Interacoustics Otoread system in response to 83 dB SPL clicks. TEOAEs were obtained in response to 300 stimuli with artifact-free responses and ABRs to 2 averages, each with 1,024 clean responses. A typical ABR from a newborn is shown in Figure 1. Two initial ABRs were compared for consistency and averaged. Three peaks were marked for latency in milliseconds and amplitude from peak to following trough in microvolt. All ABR scoring was reviewed by the first author and corrected if necessary.

Fig. 1.

Typical newborn ABR elicited by 80 dB nHL clicks. The peaks of waves I, III, and V are labeled. The arrows indicate the peak to following trough amplitudes. The latency in ms and the amplitude in μV for each peak, along with interpeak time intervals, make up the data points for the ABR from each ear. ABR, auditory brainstem response.

Fig. 1.

Typical newborn ABR elicited by 80 dB nHL clicks. The peaks of waves I, III, and V are labeled. The arrows indicate the peak to following trough amplitudes. The latency in ms and the amplitude in μV for each peak, along with interpeak time intervals, make up the data points for the ABR from each ear. ABR, auditory brainstem response.

Close modal

The TEOAE averaged waveform is split into 2 buffers created by positive and negative polarity stimuli. These buffers are subtracted to compute the background noise and added to produce the overall TEOAE response in dB SPL. TEOAE and noise spectra were sampled at 1.5k, 2k, 2.5k, 3k, 3.5k, and 4k Hz. Data used in analysis include the TEOAE signal level in dB SPL and the SNR.

Statistical Analyses

Mixed-design analyses of covariance (ANOVAs) (repeated measures) were computed for ABR peak latencies and peak amplitudes, with waves I, III, and V as repeated measures and TEOAE level and SNR, with individual frequencies as repeated measures, to examine the main effect of PAE, the main effect of PTE, and the interaction between the two exposures. In addition, ANOVAs were applied to the ABR interpeak intervals of I–III, III–V, and I–V. Both ABR and TEOAE measures have been shown to be dependent upon GA at birth [65-68], sex [69, 70], and postnatal age in hours of life (HOL) at the time of assessment [66, 71, 72]. Analyses controlled for these factors and for the clinical center. In addition, the PAE analysis controlled for PTE and vice versa. The analyses of 1-month metrics followed the same procedure except that HOL was not included as a covariate because the influence of HOL has not been demonstrated beyond the first 48 hours [72].

ABR latency has been shown to be influenced by head circumference [73-76] and reduced head circumference has been associated with PTE [77]. Accordingly, the association between PTE and head circumference was analyzed.

A summary of F and p values found for repeated-measures analyses can be found in Table 4. Those found for interpeak intervals are shown in Table 5.

Table 4.

Results of repeated measures analyses of variance for ABR and TEOAE by exposures for newborn and 1-month assessments

Results of repeated measures analyses of variance for ABR and TEOAE by exposures for newborn and 1-month assessments
Results of repeated measures analyses of variance for ABR and TEOAE by exposures for newborn and 1-month assessments
Table 5.

Results of analyses of variance for ABR interpeak intervals I–III, III–V, and I–V by exposure for newborn and 1-month assessments

Results of analyses of variance for ABR interpeak intervals I–III, III–V, and I–V by exposure for newborn and 1-month assessments
Results of analyses of variance for ABR interpeak intervals I–III, III–V, and I–V by exposure for newborn and 1-month assessments

Auditory Brainstem Response

Newborns

PTE had a significant effect on newborn ABR latency in the right (p = 0.001) and left (p = 0.026) ears as shown in Figure 2a. An interaction between PTE and PAE on newborn ABR latency was found in the left ear only (p = 0.037) as shown in Figure 3. PAE alone did not influence absolute peak latencies nor peak amplitudes in newborns. Newborn ABR interpeak I–III interval was significantly influenced by PAE (p = 0.007) and PTE (p = 0.038) in the right ear, but no interaction of exposures was found for this measure. The III-V interval in the left ear was significant for PAE (p = 0.022).

Fig. 2.

Significant effects of PTE on newborn ABR latency and 1-month amplitudes. Red symbols indicate the right ear and blue indicate the left ear. Significant paired exposure comparisons are indicated with *p ≤ 0.05 and **p ≤ 0.01. All mean values are adjusted by the covariates (see text). a Mean newborn ABR peak latencies plotted by smoking exposure with standard error bars. The overall effect was significant in the right (p = 0.001) and left ears (p = 0.026). b Mean ABR peak amplitudes from 1-month-old infants plotted by exposure cluster with standard error bars. The overall effect was significant in the right (p = 0.001) and left ears (p = 0.004). UE, unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; ABR, auditory brainstem response.

Fig. 2.

Significant effects of PTE on newborn ABR latency and 1-month amplitudes. Red symbols indicate the right ear and blue indicate the left ear. Significant paired exposure comparisons are indicated with *p ≤ 0.05 and **p ≤ 0.01. All mean values are adjusted by the covariates (see text). a Mean newborn ABR peak latencies plotted by smoking exposure with standard error bars. The overall effect was significant in the right (p = 0.001) and left ears (p = 0.026). b Mean ABR peak amplitudes from 1-month-old infants plotted by exposure cluster with standard error bars. The overall effect was significant in the right (p = 0.001) and left ears (p = 0.004). UE, unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; ABR, auditory brainstem response.

Close modal
Fig. 3.

Average latency of newborn ABR from the left ear with combined alcohol and tobacco exposures. The interaction between alcohol and tobacco exposures on left ear latencies (average of I, III, and V) is significant at p = 0.037. Values plotted are means with standard error bars. Significant pairwise latency comparisons include alcohol QE with smoking UE versus LCQE p = 0.004, alcohol Con with smoking UE versus HMC p = 0.047, and smoking LCQE with alcohol UE versus QE p = 0.007. UE, Unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; QE, Quit Early; Con, Continuous; ABR, auditory brainstem response.

Fig. 3.

Average latency of newborn ABR from the left ear with combined alcohol and tobacco exposures. The interaction between alcohol and tobacco exposures on left ear latencies (average of I, III, and V) is significant at p = 0.037. Values plotted are means with standard error bars. Significant pairwise latency comparisons include alcohol QE with smoking UE versus LCQE p = 0.004, alcohol Con with smoking UE versus HMC p = 0.047, and smoking LCQE with alcohol UE versus QE p = 0.007. UE, Unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; QE, Quit Early; Con, Continuous; ABR, auditory brainstem response.

Close modal

The effect of PTE on the newborn ABR was a reduction of the peak latencies as shown in Figure 2a. The significance of individual paired comparisons of latency with exposure is indicated with star symbols. In no instance was the difference between the latency of the “Unexposed” and the “LCQE” smoking conditions significant. All “Unexposed” and “HMC” comparisons were significant except for wave V in the left ear which approached but did not reach significance at p = 0.063.

A significant interaction was found between newborn alcohol and tobacco exposures regarding ABR latency for the left ear only (p = 0.037) as shown in Figure 3. This was the only instance in which PAE was shown to affect the newborn ABR absolute latencies.

One Month

At 1 month of age, PTE had a significant effect on ABR amplitude in the right (p = 0.001) and left (p = 0.004) ears as shown in Figure 2b. PTE was also found to have a significant influence on the I–V interpeak interval in the left ear (p = 0.002) at 1 month.

Analysis of absolute ABR metrics from infants with tobacco exposure at 1-month of age revealed a significant decline in peak amplitude in the left (p = 0.004) and right (p = 0.001) ears. The amplitudes are plotted by exposure in Figure 2b. Amplitude reductions were greatest in the “Unexposed” to “LCQE” comparisons. These were significant in both ears and for all peaks except for the left ear for wave III. Wave III overall showed the least change in amplitude with tobacco exposure. Also, while wave I showed a continuous decline in amplitude with exposure, wave V showed no change or a very slight increase in amplitude with the highest level of exposure when compared to the “LCQE” condition.

Transient Otoacoustic Emissions

Neither alcohol nor tobacco exposures were associated with changes in the newborn TEOAE measures. However, a significant alcohol exposure effect was found for the TEOAE in the left ear only of infants at 1 month of age (p = 0.011). Figure 4a displays the effects of alcohol exposures on the frequency bands of the TEOAE in both ears. The reduction in the TEOAE amplitude on the left was greatest in the mid-frequency regions from 2.0 to 3.5k Hz. No similar trends in TEOAE amplitudes due to alcohol exposure were seen in the right ear. Alcohol exposure did not produce significant effects on the overall SNR of the TEOAE although the 2 measures are closely related. The SNR is the TEOAE amplitude divided by the background noise. SNR values are plotted by alcohol exposure for each ear in Figure 4b. While the overall repeated measures in the left ear were not significant (p = 0.158), 3k Hz and 3.5k Hz pairwise exposure comparisons for the SNR were significant. These 2 frequencies demonstrated the same pattern shown for the TEOAE alone, that is, the greatest reduction in amplitude in the “Continuous Alcohol” group and in the mid-frequency region. Neither the overall SNR nor any of the pairwise comparisons were significant in the right ear. This further emphasizes the TEOAE ear asymmetry in response to alcohol exposure.

Fig. 4.

PAE effects on TEOAEs at 1 month are significant in the left ear only. Significant paired exposure comparisons are indicated with *p ≤ 0.05 and **p ≤ 0.01. All mean values are adjusted by the covariates (see text) and error bars indicate a standard error. a Mean amplitude of TEOAE frequency bands plotted as a function of alcohol clusters from 1-month-old infants. The overall significance of alcohol exposure on TEOAE amplitude in the left ear is p = 0.011 and in the right is p = 0.746. b Mean TEOAE SNR by frequency bands plotted as a function of alcohol clusters from 1-month-old infants. Neither ear demonstrated significant alcohol exposure effects on SNR with the overall p value from the left ear = 0.158 and the right ear = 0.394. Two frequencies in the left ear (3k and 3.5k Hz) demonstrated significant pairwise alcohol effects with the continuous exposure showing the greatest reduction in SNR. PAE, prenatal alcohol exposure; TEOAEs, transient otoacoustic emissions; SNR, signal-to-noise ratio.

Fig. 4.

PAE effects on TEOAEs at 1 month are significant in the left ear only. Significant paired exposure comparisons are indicated with *p ≤ 0.05 and **p ≤ 0.01. All mean values are adjusted by the covariates (see text) and error bars indicate a standard error. a Mean amplitude of TEOAE frequency bands plotted as a function of alcohol clusters from 1-month-old infants. The overall significance of alcohol exposure on TEOAE amplitude in the left ear is p = 0.011 and in the right is p = 0.746. b Mean TEOAE SNR by frequency bands plotted as a function of alcohol clusters from 1-month-old infants. Neither ear demonstrated significant alcohol exposure effects on SNR with the overall p value from the left ear = 0.158 and the right ear = 0.394. Two frequencies in the left ear (3k and 3.5k Hz) demonstrated significant pairwise alcohol effects with the continuous exposure showing the greatest reduction in SNR. PAE, prenatal alcohol exposure; TEOAEs, transient otoacoustic emissions; SNR, signal-to-noise ratio.

Close modal

TEOAEs that did not meet criterion SNR were removed before data analysis for reasons stated in the methods section. To determine if exposure was related to pass/fail status, a χ2 analysis was conducted on the distributions of pass/fail for smoking groups and alcohol groups. The comparison of the proportion of newborns with a “fail” in one or both ears to those with “pass” status in both ears was significant for PTE (χ2 = 8.713, p = 0.013) as shown in Figure 5. The percentage of failed TEOAEs was higher in smoking groups and lower in the nonsmoking group. There was no association between pass/fail status and PAE and no association of alcohol or smoking with pass/fail status at 1 month of age.

Fig. 5.

Newborn TEOAE “pass/fail” status by smoking clusters. A “pass” required that 4 of the 6 frequency bands have an SNR >4 dB. Failed results indicate a fail in one or both ears. Results of χ2 = 8.713, p = 0.013. UE, Unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; TEOAE, transient otoacoustic emission; SNR, signal-to-noise ratio.

Fig. 5.

Newborn TEOAE “pass/fail” status by smoking clusters. A “pass” required that 4 of the 6 frequency bands have an SNR >4 dB. Failed results indicate a fail in one or both ears. Results of χ2 = 8.713, p = 0.013. UE, Unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; TEOAE, transient otoacoustic emission; SNR, signal-to-noise ratio.

Close modal

Head Circumference

The effect of PTE and PAE on infant head circumference was analyzed by ANOVA. PTE was shown to have a significant effect on head circumference in the newborn stage (p = 0.002) but not at 1 month of age (p = 0.476). The pattern of effects showed a large reduction in head circumference between the “Unexposed” and “LCQE” exposures (p = 0.001). Average head circumference increased slightly between “LCQE” and “HMC,” but this was not significant (p = 0.566). The reductions in head circumference from “Unexposed” to “HMC” were also significant (p = 0.046). PAE was not found to influence head circumference (p = 0.935) and alcohol by tobacco interaction was also not significant (p = 0.650).

Covariates

Statistics on the covariate factors for the conditions with significant exposure effects are shown in Table 2 Delivery GA was significant for newborn ABR measures but was not a factor in the 1-month amplitude measures. Sex and postnatal age (HOL) were both significant covariates for ABR measures as expected [70, 72, 78]. Clinical center also showed influence on most exposure effects. One possible explanation lies in the cultural diversity between the NPs and SA sites. Figure 6 demonstrates the values of smoking and alcohol consumption within each cluster across the trimesters comparing the 2 centers. Wide discrepancies are apparent in the amounts of exposure within each cluster across centers. These could account for the influence of center on the exposure effects.

Fig. 6.

Extent of exposures by category for the 2 clinical centers. Mean cigarettes (average per week) and alcohol (drinks per trimester) for each cluster by center and trimester are shown. Error bars indicate a standard error. NP, Northern Plains; SA, South Africa; T, trimester; UE, Unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; QE, Quit Early; Con, Continuous.

Fig. 6.

Extent of exposures by category for the 2 clinical centers. Mean cigarettes (average per week) and alcohol (drinks per trimester) for each cluster by center and trimester are shown. Error bars indicate a standard error. NP, Northern Plains; SA, South Africa; T, trimester; UE, Unexposed; LCQE, Low Continuous and Quit Early; HMC, High and Moderate Continuous; QE, Quit Early; Con, Continuous.

Close modal

In this study of the effects of PAE and PTE on the developing human auditory system, our major conclusions are as follows. First, latencies of ABR peaks elicited in both ears are reduced in newborns in response to PTE in a manner that is proportional to the exposure. Reduced latencies are apparent only with the highest level of PTE. This effect is not seen when the infants reached 1 month of age. Second, ABR peak amplitudes are reduced in response to PTE, not at birth but by 1 month of age, again bilaterally and proportional to exposure. The amplitude reduction is greatest with the lowest level of tobacco exposure. And third, an interaction of PAE and PTE on newborn ABR latencies was found only in the responses from the left ear. The pattern of interactions, as seen in Figure 3, does not show any systematic patterns. With this one exception, in one ear only, PAE did not show a significant influence on ABR measures from either age-group.

Prenatal exposures had scattered effects on ABR interpeak latencies. Both alcohol and tobacco demonstrated these effects in both age-groups. With one exception (right ear I–III interval by PTE), the absolute latencies were not influenced by the same exposures. Interpretation of interpeak intervals that do not show a corresponding overall effect on absolute latencies is questionable. The interpeak interval findings were also unilateral in all instances. Given the shared generators of the ABR elicited by each ear, any important change in neural conduction time should have been reflected on both sides [2].

Newborn TEOAEs were not significantly affected by either exposure. However, the response was reduced significantly in the left ear of the 1-month-old infants by exposure to PAE. This finding is discussed in detail below.

Although not part of the primary analysis of effects, a significant increase in poor TEOAE responses was found in newborns with PTE. This finding is in line with increased incidence of otitis media in infants with PTE [19]. Middle ear disease is known to reduce or eliminate the TEOAE regardless of the status of the cochlea [79, 80].

ABR Latency Reduction from PTE

As has been shown in other studies [34, 35, 58], ABR latencies are shortened by PTE. This finding is consistent across ears, is seen for all ABR peaks, and occurs in a dose-dependent manner as shown in Figure 2a. Other than PTE, damage to the peripheral auditory system has previously been associated with an increase in ABR peak latencies rather than a decrease. Premature infants are known to have delayed ABR latencies [65, 66]. When used in the diagnosis of neurological diseases, including vestibular schwannoma, multiple sclerosis, Bell’s palsy, and others, increased ABR peak and interpeak latencies and reduced amplitudes have been found [2, 81]. In a preliminary description of unexposed infants from this study’s population, Sininger et al. [5] demonstrated that the latency of all ABR peaks was reduced and the amplitude increased over the first month of life. A variety of mechanisms have been postulated for the rapid decrease in ABR peak latency in the first month of life including improved middle ear transmission [82, 83]. This study found that PTE reduced latencies in all 3 ABR peaks including wave I, which is generated in the most peripheral portion of the auditory nerve [84]. Kable et al. [34] found significantly shortened latencies for wave V only but also demonstrated reduced latency for waves I and III that were proportional to exposure but did not reach statistical significance. The discrepancy between studies could have been due to differences in the sample size.

Reduced head circumference has been associated with reduced brainstem length [73] and with shortened ABR peak and interpeak latencies [73-76]. A reduction in head circumference was associated with PTE in this population. However, the pattern of effects of PTE on head circumference changes cannot predict the changes seen in latency. The lowest level of PTE results in significant reduction in head circumference but not in ABR latency reductions. Also, adding head circumference to the covariates in the smoking by latency ANOVAs did not reduce the significance of the effect. Therefore, while intriguing, head circumference reductions due to tobacco exposure cannot be the explanation for reduced ABR latencies.

A plausible candidate for the source of reduced ABR latencies is altered synaptic transmission at the IHC-spiral ganglion neuron intersection. Nicotine toxicity is the most likely source of damage from PTE and systems involving nicotinic receptors are the likely target of such involvement. Animal preparations have shown that prenatal nicotine exposure consistently leads to an upregulation of presynaptic, nicotinic ACh receptors (nAChRs) [85, 86] and such exposure impairs the ability of the receptors to modulate the release of both inhibitory and excitatory neurotransmitters [87].

The explanation for prenatal nicotine exposure effects on ABR peak latencies in early development involves the cholinergic olivocochlear system, which modulates activity in the hair cells and early segments of the auditory nerve [11, 88, 89]. The medial and lateral olivocochlear (MOC and LOC) efferent neurons make up a descending pathway originating in the superior olivary complex in the brainstem. Olivocochlear efferents contact the IHC and OHC as well as the primary portion of the auditory nerve early in development [90].

The MOC neurons are primarily, if not exclusively, cholinergic and innervate the OHCs in the mature auditory system [91, 92]. However, of particular importance to the interpretation of data from this study is the fact that cholinergic MOC fibers, during the very earliest stages of hearing development in mammals, before innervation of OHCs, transiently project directly to the IHCs communicating via α9- and α10-nAChRs [93-97]. In rodents, the direct innervation of IHC by the MOC happens just after birth and lasts through the second postnatal week [98, 99].

The role of efferent innervations to the developing hair cells is to set activity patterns in the cells and the synaptic structures. Functional nAChRs mostly of the α9 and α10 subtype are found on rodent IHCs and MOC fibers just after birth [99] where they promote synaptic maturation and stabilization during early development [100, 101]. Johnson et al. [102] studied the IHC ribbon synapse in an α9 nAChR knockout mouse model to demonstrate that the efferent system was required for normal synaptic development.

Latency reductions in ABR wave I that accompany PTE could be explained by a transient increase in synaptic efficiency at the IHC. Such effects could occur during early (third trimester) MOC innervation of the IHC, which, due to the nicotine exposure, may result in an overproduction of nAChRs. A reduction of newborn ABR latencies with PTE was not seen in the infants with “LCQE” exposures but was substantial for infants born to mothers with “HMC” smoking. Differences could relate to either the timing or degree of exposure or both. According to Moore and Linthicum [90], the MOC innervation of the IHC in humans would be expected around the beginning of the third trimester, which is after the timing of the smoking cession in the “quit early” mothers. If the temporary influence of the MOC on the IHC is implicated in reduced latencies of the ABR, infants of mothers who quit early would be expected to be sparred.

It could be argued that increased ABR peak amplitude should accompany reduced latency when synaptic efficiency increases. However, no such amplitude increase was observed. For this theory to be valid, increased synaptic activity would need to be reflected in synaptic timing rather than in numbers of nerve fibers activated. The reduced latencies in waves III and V could be a simple reflection of upstream shortened latency of wave I. Mechanisms involving other than the initial synapse might have been expected to change interpeak latencies, but no consistent or bilateral changes in interpeak latency were found.

The finding of reduced ABR peak latency with PTE was not observed at 1 month of age. This indicates that the effects of PTE on the latency of the ABR are overcome after the newborn period. Kable et al. [34] found reduced ABR latencies in PTE infants at 6 months of age, but these were only significant for wave V. It should be noted that the sample size of ABR data in this study was reduced at 1 month with 925 participants as compared to 2,613 in the newborn period. This was not due to lost participants, rather to an emphasis on TEOAE measures at 1 month. However, examination of 1-month ABR data relative to smoking clusters demonstrated a (nonsignificant) trend for latency to increase with exposure. This would argue against missing a latency reduction at 1 month due to insufficient sample size.

ABR Amplitude Reduction in 1-Month Infants

After 1 month of age, ABR amplitudes, particularly for peaks I and V, were found to be reduced in infants with PTE. Amplitude reductions were found in ABRs elicited from both left and right ears and were reduced in proportion to PTE as shown in Figure 2b. A study of 54 early demise fetuses and infants examined brainstem samples, which were subjected to AChR immunohistochemistry. Thirty-four of the infant’s mothers were confirmed smokers and 20 were nonsmokers. Only in the samples with tobacco exposure were high levels of α7-nAChR expression observed along with hypoplasia of some brainstem structures [103]. Perinatal nicotine exposure also has been shown to disrupt the maturation of glutamatergic inputs in the auditory brainstem, specifically delaying the developmental downregulation of functional nAChRs in a mouse model. A dramatic reduction in the synaptic input amplitude in the lateral lemniscus was also seen [104]. Any of the aforementioned mechanisms could explain the reduction of amplitude in the ABRs of the 1-month-old infants.

Unlike the smoking effects on newborn latencies, the effects seen at 1 month of age on amplitude are found with both the “LCQE” and “HMC” exposures. This indicates that all levels and timing of PTE will lead to reduced amplitudes of the auditory system brainstem activity.

Unilateral PAE Effects on TEOAEs

Clear evidence of reduced amplitude of the TEOAEs was found in association with PAE, in the left ear only. TEOAEs are generated by the OHCs in each ear, which are known to be sensitive to effects of oxygen deprivation, and hypoxia has often been associated with PAE [105-108]. However, hypoxia would certainly affect the hair cells of both ears and therefore cannot explain reduced amplitude of the OAE in one ear only.

The major damage associated with PAE, especially during brain growth spurts in the last trimester, is massive neuron loss due to apoptosis [109, 110]. The cerebral cortex is one of the most damaged areas of the brain, and within the cortex, pyramidal neurons of layer 5 are more susceptible to the effects of alcohol than cells in other layers [111, 112]. Layer 5 of the auditory cortex is also the origin of efferent neurons that innervate the inferior colliculus and medial geniculate [113] and continue to the superior and lateral olive. Corticofugal influences on the inner ear begin in the auditory cortex and descend via the brainstem to the olivocochlear neurons. Axons descending from the human inferior colliculus to the olivocochlear neurons can be seen in staining between the 22nd and 26th weeks of gestation [90].

PAE has been shown to cause asymmetrical damage to the developing brain with greater damage to structures in the right hemisphere [114]. Specific damage to the right temporal lobe has often been reported in relation to PAE in studies using MRI. Rajaprakash et al. [115] noted a reduced cortical surface area in the right superior temporal gyrus of children aged 8–16 years with PAE as compared to unexposed controls. Chen et al. [43] using structural MRI found that young adults with PAE, when contrasted to control subjects, demonstrated reduced volume in the right inferior temporal gyrus. Lebel et al. [116] looked at longitudinal changes in cortical volume in children and youth comparing those with PAE to controls. They found that the right transverse temporal lobe regions were negatively correlated with PAE; greater alcohol exposures were associated with larger decreases in volume from MRI scans spaced 2 years apart.

Perhaps, the most convincing data on damage specifically to the right temporal lobe in response to PAE come from Sowell and colleagues [117]. They utilized cortical matching techniques to examine hemispheric asymmetry in adolescents with heavy PAE and controls and found that alcohol-exposed individuals had significantly reduced “right to left” ratios based on both surface and volumetric image analysis in the posterior temporal lobes. The authors point out that right greater than left asymmetry in the posterior temporal lobes [118] is still noted in most MRIs from participants with PAE. However, there is a significant reduction in this asymmetry associated with alcohol exposure.

The auditory efferent system connects the auditory cortex to the cochlea through a series of afferent-efferent feedback loops [119]. Damage to the right hemisphere temporal lobe will influence the left side of the peripheral auditory system via the crossed descending pathways. MOC inhibition of the OHC is a well-known phenomenon, which can be evaluated in mature auditory systems with a technique known as the Medal Olivocochlear Reflex (MOCR) [120]. Effects of activation of cortical neurons can be seen in cochlear functions including otoacoustic emissions. Removal of parts of the temporal lobe in patients with epilepsy will alter the MOCR particularly in the ear contralateral to the ablation [121]. In a study of patients scheduled for temporal ablations, direct electrical stimulation of the cortex was shown to significantly reduce the amplitude of the TEOAE in the ear contralateral to the stimulation [122]. Central damage to the auditory regions of the right hemisphere from PAE could translate to disruption of peripheral MOC innervation on the left ear due to a primarily crossed pathway.

The exact mechanism by which the reduction of the otoacoustic emission might be brought about by unilateral disruption of efferent stimulation is unclear. The left ear amplitude reduction seen in this study could reflect the partial damage to the outer hair cells or abnormal activation of the MOCR. In the developing auditory system, neither efferent stimulation nor innervation has been shown to be necessary for the OHC electromotility that produces the otoacoustic emission [123]. However, damage to the descending pathway would reduce the MOC activation at the level of the cochlea and interruption of MOC activation has been linked to increased damage to hair cells from mechanisms such as noise exposure [124] and aging [125].

The distinct asymmetry in the presentation of TEOAEs following PAE could allow this simple measure to be utilized as a biomarker for alcohol exposure. OAEs and ABRs have been explored as diagnostic indicators of other childhood disorders, primarily autism spectrum disorder (ASD). Otoacoustic emission amplitudes [126] and ABR indices, primarily latencies [127-129], have been shown to distinguish children with ASD from controls. The MOCR [130] has been shown to correlate with hyperacusis in children with ASD. However, none of these potential indices for autism have found an asymmetric response.

This study represents the largest sample of mother-infant dyads with carefully documented maternal use of tobacco and alcohol and neonatal auditory system outcomes. Prenatal tobacco use resulted in disruption of responses at the brainstem level at both the newborn timeframe (shortened ABR latencies) and the 1-month timeframe (reduced ABR amplitude). Reduced latencies may be attributable to prenatal disruption of synaptic mechanisms at the inner hair cell and the later amplitude reductions to cell damage in the brainstem. PTE was also associated with an increase in the number of infants that failed the TEOAE test. This was likely an epiphenomenon due to increased middle ear disease and not a reflection of outer hair cell damage accompanying PTE. Otherwise, no cochlear effects were found in infants exposed to tobacco; the TEOAE of infants with a robust response was not influenced by the exposure. In contrast, prenatal exposure to alcohol was found to show no effect on brainstem measures but led to a significant reduction in the cochlear response (TEOAE) in the left ear only of 1-month-old infants. This unilateral finding is felt to reflect cortical damage to the right temporal lobe, which sends information to the left cochlea via the corticofugal and olivocochlear efferent systems. This finding opens the possibility of the TEOAE test as a potential biomarker for PAE.

The PASS Network is solely responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The following researchers compose the PASS Network:

  • PASS Steering Committee Chair (University of Texas Medical Branch): Gary D.V. Hankins, MD.

  • Data Coordinating & Analysis Center (DM-STAT, Inc.): PI: Kimberly A. Dukes, PhD; Co-PI: Lisa M. Sullivan, PhD; Biostatistics: Tara Tripp, MA; Fay Robinson, MPH; and Cheri Raffo, MPH; Project Management/Regulatory Affairs: Julie M. Petersen, BA; and Rebecca A. Young, MPH; Statistical Programming/Data Management: Cindy Mai, BA; and Elena Grillo, MBA BS, BBA; Data Management/Information Technology: Travis Baker, BS; Patti Folan; Gregory Toland, MS; and Michael Carmen, MS.

  • Developmental Biology & Pathology Center (Children’s Hospital Boston): PI: Hannah C. Kinney, MD; Assistant Director: Robin L. Haynes, PhD; Coinvestigators: Rebecca D. Folkerth, MD; Ingrid A. Holm, MD; Theonia Boyd, MD; David S. Paterson, PhD; Hanno Steen, PhD; Kyriacos Markianos, PhD; Drucilla Roberts, MD; Kevin G. Broadbelt, PhD; Richard G. Goldstein, MD; Laura L. Nelsen, MD; Jacob Cotton, BS; and Perri Jacobs, BS.

  • Comprehensive Clinical Site Northern Plains (Sanford Research): PI: Amy J. Elliott, PhD; Co-PI: Larry Burd, PhD; Coinvestigators: Jyoti Angal, MPH; Jessica Gromer, RN; H. Eugene Hoyme, MD; Margaret Jackson, BA; Luke Mack, MA; Bradley B. Randall, MD; Mary Ann Sens, MD; Deborah Tobacco, MA; and Peter Van Eerden, MD.

  • Comprehensive Clinical Site South Africa (Stellenbosch University): PI: Hendrik Odendaal, MBChB, FRCOG, MD; Co-PI: Colleen Wright, MD, FRCPath, PhD; Coinvestigators: Lut Geerts, MD, MRCOG; Greetje de Jong, MBChB, MMed, MD; Pawel Schubert, FCPath (SA) MMed; Shabbir Wadee, MMed; Johan Dempers, FCFor Path (SA); Elsie Burger, FCFor Path (SA), MMed Forens Path; and Janetta Harbron, PhD; Coinvestigator & Project Manager: Coen Groenewald, MBChB, MMed, FCOG, M. Comm.

  • Physiology Assessment Center (Columbia University): Co-PIs: William Fifer, PhD; Michael Myers, PhD; Coinvestigators: Joseph Isler, PhD; Yvonne Sininger, PhD; Project Management: J. David Nugent, MA; and Carmen Condon, BA; Data Analysis: Margaret C. Shair, BA; and Tracy Thai, MA.

  • NIH Project Scientists: Marian Willinger, PhD (NICHD); Dale Hereld, MD, PhD (NIAAA); Howard J. Hoffman, MA (NIDCD); and Chuan-Ming Li, MD, PhD (NIDCD).

We would like to thank Dr. Jos Eggermont for helpful suggestions regarding interpretation of results.

This research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. Details of enrollment policies can be found in the Methods section under Participants and are published in Dukes et al. [59].

The authors have no conflicts of interest to declare.

Research reported in this publication was supported by National Institutes of Health grants U01HD055154, U01HD045935, U01HD055155, U01HD045991, and U01AA016501 funded by the National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute on Deafness and Other Communication Disorders.

Drs Yvonne S. Sininger and William P. Fifer had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis; Yvonne S. Sininger, Michael M. Myers, Amy J. Elliott, William P. Fifer, Hein J. Odendaal, and Howard J. Hoffman were involved in study concept and design; Carmen G. Condon, Tracy Thai, Amy J. Elliott, Hein J. Odendaal, Jyoti Angal, and Deborah Tobacco assisted with data acquisition; Yvonne S. Sininger, Dwayne D. Simmons, Carmen G. Condon, Lauren C. Shuffrey, Lissete A. Gimenez, Nicolò Pini, James D. Nugent, Michael M. Myers, and William P. Fifer performed data analysis or interpretation; Yvonne S. Sininger, Carmen G. Condon, Lissete A. Gimenez, and Lauren C. Shuffrey drafted the manuscript; Michael M. Myers, Amy J. Elliott, William P. Fifer, and Hein J. Odendaal obtained funding; Carmen G. Condon, Hein J. Odendaal, Howard J. Hoffman, William P. Fifer, and Amy J. Elliott contributed administrative, technical, or material support; Carmen G. Condon, Hein J. Odendaal, Coen Groenewald, Amy J. Elliott, William P. Fifer, Jyoti Angal, and Deborah Tobacco were involved in study supervision.

The data that support the findings of this study are not publicly available due to involvement of Tribal Nations that preclude data sharing. Please contact the corresponding author if you have any questions or would like more information.

1.
Wilkinson
AR
,
Jiang
ZD
.
Brainstem auditory evoked response in neonatal neurology
.
Semin Fetal Neonatal Med
.
2006
;
11
(
6
):
444
51
. .
2.
Eggermont
JJ
.
Auditory brainstem response
.
Handb Clin Neurol
.
2019
;
160
:
451
64
. .
3.
Oostenbrink
P
,
Verhaagen-Warnaar
N
.
Otoacoustic emissions
.
Am J Electroneurodiagnostic Technol
.
2004
;
44
(
3
):
189
98
. .
4.
Shera
CA
.
Mechanisms of mammalian otoacoustic emission and their implications for the clinical utility of otoacoustic emissions
.
Ear Hear
.
2004
;
25
(
2
):
86
97
. .
5.
Sininger
YS
,
Condon
CG
,
Hoffman
HJ
,
Elliott
AJ
,
Odendaal
HJ
,
Burd
LL
,
Transient otoacoustic emissions and auditory brainstem responses in low-risk cohort of newborn and one-month-old infants: assessment of infant auditory system physiology in the prenatal alcohol in SIDS and stillbirth network safe passage study
.
J Am Acad Audiol
.
2018
;
29
(
8
):
748
63
. .
6.
Jewett
DL
,
Romano
MN
,
Williston
JS
.
Human auditory evoked potentials: possible brain stem components detected on the scalp
.
Science
.
1970
;
167
(
3924
):
1517
8
. .
7.
Moore
JK
,
Ponton
CW
,
Eggermont
JJ
,
Wu
BJ
,
Huang
JQ
.
Perinatal maturation of the auditory brain stem response: changes in path length and conduction velocity
.
Ear Hear
.
1996
;
17
(
5
):
411
8
. .
8.
Ponton
CW
,
Moore
JK
,
Eggermont
JJ
.
Auditory brain stem response generation by parallel pathways: differential maturation of axonal conduction time and synaptic transmission
.
Ear Hear
.
1996
;
17
(
5
):
402
10
. .
9.
Kemp
DT
.
Stimulated acoustic emissions from within the human auditory system
.
J Acoust Soc Am
.
1978
;
64
(
5
):
1386
91
. .
10.
Ashmore
J
,
Avan
P
,
Brownell
WE
,
Dallos
P
,
Dierkes
K
,
Fettiplace
R
,
The remarkable cochlear amplifier
.
Hear Res
.
2010
;
266
(
1–2
):
1
17
. .
11.
Guinan
JJ
 Jr
.
Olivocochlear efferents: their action, effects, measurement and uses, and the impact of the new conception of cochlear mechanical responses
.
Hear Res
.
2018
;
362
:
38
47
. .
12.
Church
MW
,
Abel
EL
.
Fetal alcohol syndrome. Hearing, speech, language, and vestibular disorders
.
Obstet Gynecol Clin North Am
.
1998
;
25
(
1
):
85
97
. .
13.
England
LJ
,
Aagaard
K
,
Bloch
M
,
Conway
K
,
Cosgrove
K
,
Grana
R
,
Developmental toxicity of nicotine: a transdisciplinary synthesis and implications for emerging tobacco products
.
Neurosci Biobehav Rev
.
2017
;
72
:
176
89
. .
14.
Zhou
S
,
Rosenthal
DG
,
Sherman
S
,
Zelikoff
J
,
Gordon
T
,
Weitzman
M
.
Physical, behavioral, and cognitive effects of prenatal tobacco and postnatal secondhand smoke exposure
.
Curr Probl Pediatr Adolesc Health Care
.
2014
;
44
(
8
):
219
41
. .
15.
Römer
P
,
Mathes
B
,
Reinelt
T
,
Stoyanova
P
,
Petermann
F
,
Zierul
C
.
Systematic review showed that low and moderate prenatal alcohol and nicotine exposure affected early child development
.
Acta Paediatr
.
2020
;
109
(
12
):
2491
501
.
16.
Lambers
DS
,
Clark
KE
.
The maternal and fetal physiologic effects of nicotine
.
Semin Perinatol
.
1996
;
20
(
2
):
115
26
. .
17.
DiFranza
JR
,
Aligne
CA
,
Weitzman
M
.
Prenatal and postnatal environmental tobacco smoke exposure and children’s health
.
Pediatrics
.
2004
;
113
(
4 Suppl l
):
1007
15
.
18.
Fried
PA
,
Watkinson
B
.
12- and 24-Month neurobehavioural follow-up of children prenatally exposed to marihuana, cigarettes and alcohol
.
Neurotoxicol Teratol
.
1988
;
10
(
4
):
305
13
. .
19.
Håberg
SE
,
Bentdal
YE
,
London
SJ
,
Kvaerner
KJ
,
Nystad
W
,
Nafstad
P
.
Prenatal and postnatal parental smoking and acute otitis media in early childhood
.
Acta Paediatr
.
2010
;
99
(
1
):
99
105
. .
20.
Ilicali
OC
,
Keleş
N
,
De er
K
,
Sa un
OF
,
Güldíken
Y
.
Evaluation of the effect of passive smoking on otitis media in children by an objective method: urinary cotinine analysis
.
Laryngoscope
.
2001
;
111
(
1
):
163
7
. .
21.
Weitzman
M
,
Govil
N
,
Liu
YH
,
Lalwani
AK
.
Maternal prenatal smoking and hearing loss among adolescents
.
JAMA Otolaryngol Head Neck Surg
.
2013
;
139
(
7
):
669
77
. .
22.
Sexton
M
,
Fox
NL
,
Hebel
JR
.
Prenatal exposure to tobacco: II. Effects on cognitive functioning at age three
.
Int J Epidemiol
.
1990
;
19
(
1
):
72
7
. .
23.
Fried
PA
,
O’Connell
CM
,
Watkinson
B
.
60- and 72-Month follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol: cognitive and language assessment
.
J Dev Behav Pediatr
.
1992
;
13
(
6
):
383
91
. .
24.
Fried
PA
,
Watkinson
B
,
Gray
R
.
Differential effects on cognitive functioning in 9- to 12-year olds prenatally exposed to cigarettes and marihuana
.
Neurotoxicol Teratol
.
1998
;
20
(
3
):
293
306
. .
25.
Fried
PA
,
Watkinson
B
.
36- and 48-Month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol
.
J Dev Behav Pediatr
.
1990
;
11
(
2
):
49
58
. .
26.
Olds
DL
,
Henderson
CR
 Jr
,
Tatelbaum
R
.
Intellectual impairment in children of women who smoke cigarettes during pregnancy
.
Pediatrics
.
1994
;
93
(
2
):
221
7
.
27.
Fried
PA
,
Watkinson
B
,
Siegel
LS
.
Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana
.
Neurotoxicol Teratol
.
1997
;
19
(
3
):
171
83
. .
28.
Fried
PA
,
Makin
JE
.
Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population
.
Neurotoxicol Teratol
.
1987
;
9
(
1
):
1
7
. .
29.
Fried
PA
,
Watkinson
B
,
Gray
R
.
Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana
.
Neurotoxicol Teratol
.
2003
;
25
(
4
):
427
36
. .
30.
Picone
TA
,
Allen
LH
,
Olsen
PN
,
Ferris
ME
.
Pregnancy outcome in North American women. II. Effects of diet, cigarette smoking, stress, and weight gain on placentas, and on neonatal physical and behavioral characteristics
.
Am J Clin Nutr
.
1982
;
36
(
6
):
1214
24
. .
31.
Saxton
DW
.
The behaviour of infants whose mothers smoke in pregnancy
.
Early Hum Dev
.
1978
;
2
(
4
):
363
9
. .
32.
Kristjansson
EA
,
Fried
PA
,
Watkinson
B
.
Maternal smoking during pregnancy affects children’s vigilance performance
.
Drug Alcohol Depend
.
1989
;
24
(
1
):
11
9
. .
33.
McCartney
JS
,
Fried
PA
,
Watkinson
B
.
Central auditory processing in school-age children prenatally exposed to cigarette smoke
.
Neurotoxicol Teratol
.
1994
;
16
(
3
):
269
76
. .
34.
Kable
JA
,
Coles
CD
,
Lynch
ME
,
Carroll
J
.
The impact of maternal smoking on fast auditory brainstem responses
.
Neurotoxicol Teratol
.
2009
;
31
(
4
):
216
24
. .
35.
Katbamna
B
,
Klutz
N
,
Pudrith
C
,
Lavery
JP
,
Ide
CF
.
Prenatal smoke exposure: effects on infant auditory system and placental gene expression
.
Neurotoxicol Teratol
.
2013
;
38
:
61
71
. .
36.
Korres
S
,
Riga
M
,
Balatsouras
D
,
Papadakis
C
,
Kanellos
P
,
Ferekidis
E
.
Influence of smoking on developing cochlea. Does smoking during pregnancy affect the amplitudes of transient evoked otoacoustic emissions in newborns?
Int J Pediatr Otorhinolaryngol
.
2007
;
71
(
5
):
781
6
. .
37.
Durante
AS
,
Nascimento
CMD
,
Lopes
C
.
Otoacoustic emissions in neonates exposed to smoke during pregnancy
.
Braz J Otorhinolaryngol
.
2021
;
87
(
2
):
193
9
.
38.
Riley
EP
,
Infante
MA
,
Warren
KR
.
Fetal alcohol spectrum disorders: an overview
.
Neuropsychol Rev
.
2011
;
21
(
2
):
73
80
. .
39.
Wozniak
JR
,
Riley
EP
,
Charness
ME
.
Clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder
.
Lancet Neurol
.
2019
;
18
(
8
):
760
70
. .
40.
Mattson
SN
,
Bernes
GA
,
Doyle
LR
.
Fetal alcohol spectrum disorders: a review of the neurobehavioral deficits associated with prenatal alcohol exposure
.
Alcohol Clin Exp Res
.
2019
;
43
(
6
):
1046
62
. .
41.
Cone-Wesson
B
.
Prenatal alcohol and cocaine exposure: influences on cognition, speech, language, and hearing
.
J Commun Disord
.
2005
;
38
(
4
):
279
302
. .
42.
Astley
SJ
,
Richards
T
,
Aylward
EH
,
Olson
HC
,
Kerns
K
,
Brooks
A
,
Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders
.
Magn Reson Imaging
.
2009
;
27
(
10
):
760
78
. .
43.
Chen
X
,
Coles
CD
,
Lynch
ME
,
Hu
X
.
Understanding specific effects of prenatal alcohol exposure on brain structure in young adults
.
Hum Brain Mapp
.
2012
;
33
(
7
):
1663
76
. .
44.
Coles
CD
,
Goldstein
FC
,
Lynch
ME
,
Chen
X
,
Kable
JA
,
Johnson
KC
,
Memory and brain volume in adults prenatally exposed to alcohol
.
Brain Cogn
.
2011
;
75
(
1
):
67
77
. .
45.
Donald
KA
,
Eastman
E
,
Howells
FM
,
Adnams
C
,
Riley
EP
,
Woods
RP
,
Neuroimaging effects of prenatal alcohol exposure on the developing human brain: a magnetic resonance imaging review
.
Acta Neuropsychiatr
.
2015
;
27
(
5
):
251
69
. .
46.
Moore
EM
,
Migliorini
R
,
Infante
MA
,
Riley
EP
.
Fetal alcohol spectrum disorders: recent neuroimaging findings
.
Curr Dev Disord Rep
.
2014
;
1
(
3
):
161
72
. .
47.
Norman
AL
,
Crocker
N
,
Mattson
SN
,
Riley
EP
.
Neuroimaging and fetal alcohol spectrum disorders
.
Dev Disabil Res Rev
.
2009
;
15
(
3
):
209
17
. .
48.
Spadoni
AD
,
McGee
CL
,
Fryer
SL
,
Riley
EP
.
Neuroimaging and fetal alcohol spectrum disorders
.
Neurosci Biobehav Rev
.
2007
;
31
(
2
):
239
45
. .
49.
Zhou
D
,
Lebel
C
,
Lepage
C
,
Rasmussen
C
,
Evans
A
,
Wyper
K
,
Developmental cortical thinning in fetal alcohol spectrum disorders
.
NeuroImage
.
2011
;
58
(
1
):
16
25
. .
50.
Connor
PD
,
Streissguth
AP
,
Sampson
PD
,
Bookstein
FL
,
Barr
HM
.
Individual differences in auditory and visual attention among fetal alcohol-affected adults
.
Alcohol Clin Exp Res
.
1999
;
23
(
8
):
1395
402
. .
51.
Church
MW
,
Eldis
F
,
Blakley
BW
,
Bawle
EV
.
Hearing, language, speech, vestibular, and dentofacial disorders in fetal alcohol syndrome
.
Alcohol Clin Exp Res
.
1997
;
21
(
2
):
227
37
. .
52.
Domellöf
E
,
Rönnqvist
L
,
Titran
M
,
Esseily
R
,
Fagard
J
.
Atypical functional lateralization in children with fetal alcohol syndrome
.
Dev Psychobiol
.
2009
;
51
(
8
):
696
705
. .
53.
Rössig
C
,
Wässer
S
,
Oppermann
P
.
Audiologic manifestations in fetal alcohol syndrome assessed by brainstem auditory-evoked potentials
.
Neuropediatrics
.
1994
;
25
(
5
):
245
9
. .
54.
Kaneko
WM
,
Ehlers
CL
,
Philips
EL
,
Riley
EP
.
Auditory event-related potentials in fetal alcohol syndrome and Down’s syndrome children
.
Alcohol Clin Exp Res
.
1996
;
20
(
1
):
35
42
. .
55.
Gerhold
MM
,
Jacobson
SW
,
Jacobson
JL
,
Molteno
CD
,
Meintjes
EM
,
Andrew
CM
.
An ERP Study of response inhibition in the auditory domain in children with fetal alcohol spectrum disorders
.
Alcohol Clin Exp Res
.
2017
;
41
(
1
):
96
106
. .
56.
Stephen
JM
,
Kodituwakku
PW
,
Kodituwakku
EL
,
Romero
L
,
Peters
AM
,
Sharadamma
NM
,
Delays in auditory processing identified in preschool children with FASD
.
Alcohol Clin Exp Res
.
2012
;
36
(
10
):
1720
7
. .
57.
Hemingway
SJA
,
Davies
JK
,
Jirikowic
T
,
Olson
EM
.
What proportion of the brain structural and functional abnormalities observed among children with fetal alcohol spectrum disorder is explained by their prenatal alcohol exposure and their other prenatal and postnatal risks?
Adv Pediatr Res
.
2020
;
7
:
41
.
58.
Peck
JD
,
Neas
B
,
Robledo
C
,
Saffer
E
,
Beebe
L
,
Wild
RA
.
Intrauterine tobacco exposure may alter auditory brainstem responses in newborns
.
Acta Obstet Gynecol Scand
.
2010
;
89
(
4
):
592
6
. .
59.
Dukes
KA
,
Burd
L
,
Elliott
AJ
,
Fifer
WP
,
Folkerth
RD
,
Hankins
GD
,
The safe passage study: design, methods, recruitment, and follow-up approach
.
Paediatr Perinat Epidemiol
.
2014
;
28
(
5
):
455
65
. .
60.
Elliott
AJ
,
Kinney
HC
,
Haynes
RL
,
Dempers
JD
,
Wright
C
,
Fifer
WP
,
Concurrent prenatal drinking and smoking increases risk for SIDS: Safe Passage Study report
.
EClinicalMedicine
.
2020
;
19
:
100247
. .
61.
Jacobson
SW
,
Chiodo
LM
,
Sokol
RJ
,
Jacobson
JL
.
Validity of maternal report of prenatal alcohol, cocaine, and smoking in relation to neurobehavioral outcome
.
Pediatrics
.
2002
;
109
(
5
):
815
25
. .
62.
Angal
J
,
Petersen
JM
,
Tobacco
D
,
Elliott
AJ
.
Ethics review for a multi-site project involving tribal nations in the Northern plains
.
J Empir Res Hum Res Ethics
.
2016
;
11
(
2
):
91
6
. .
63.
Pini
N
,
Myers
MM
,
Elliott
AJ
,
Shuffrey
LC
,
Lucchini
M
,
Sania
A
,
Cluster analysis of alcohol consumption during pregnancy in the Safe Passage Study
.
Annu Int Conf IEEE Eng Med Biol Soc
.
2019
;
2019
:
1338
41
. .
64.
Shuffrey
LC
,
Myers
MM
,
Isler
JR
,
Lucchini
M
,
Sania
A
,
Pini
N
,
Association between prenatal exposure to alcohol and tobacco and neonatal brain activity: results from the Safe Passage Study
.
JAMA Netw Open
.
2020
;
3
(
5
):
e204714
. .
65.
Stipdonk
LW
,
Weisglas-Kuperus
N
,
Franken
MC
,
Nasserinejad
K
,
Dudink
J
,
Goedegebure
A
.
Auditory brainstem maturation in normal-hearing infants born preterm: a meta-analysis
.
Dev Med Child Neurol
.
2016
;
58
(
10
):
1009
15
. .
66.
Amin
SB
,
Orlando
MS
,
Dalzell
LE
,
Merle
KS
,
Guillet
R
.
Morphological changes in serial auditory brain stem responses in 24 to 32 weeks’ gestational age infants during the first week of life
.
Ear Hear
.
1999
;
20
(
5
):
410
8
. .
67.
Ribeiro
FM
,
Carvallo
RM
.
Tone-evoked ABR in full-term and preterm neonates with normal hearing
.
Int J Audiol
.
2008
;
47
(
1
):
21
9
. .
68.
Yang
HC
,
Sung
CM
,
Shin
DJ
,
Cho
YB
,
Jang
CH
,
Cho
HH
.
Newborn hearing screening in prematurity: fate of screening failures and auditory maturation
.
Clin Otolaryngol
.
2017
;
42
(
3
):
661
7
. .
69.
Cassidy
JW
,
Ditty
KM
.
Gender differences among newborns on a transient otoacoustic emissions test for hearing
.
J Music Ther
.
2001
;
38
(
1
):
28
35
. .
70.
Sininger
YS
,
Cone-Wesson
B
,
Abdala
C
.
Gender distinctions and lateral asymmetry in the low-level auditory brainstem response of the human neonate
.
Hear Res
.
1998
;
126
(
1–2
):
58
66
. .
71.
Hrnčić
N
,
Hatibović
H
,
Goga
A
,
Hodžić
D
.
Does an early discharge of a newborn influence the success of the newborn hearing screening in developing countries? A hospital based study
.
Med Glas
.
2019
;
16
(
2
). Epub ahead of print.
72.
van Dyk
M
,
Swanepoel
de W
,
Hall
JW
 3rd
.
Outcomes with OAE and AABR screening in the first 48 h – implications for newborn hearing screening in developing countries
.
Int J Pediatr Otorhinolaryngol
.
2015
;
79
(
7
):
1034
40
. .
73.
Antonelli
AR
,
Bonfioli
F
,
Nicolai
P
,
Peretti
G
.
The relationship of head and brainstem size to main parameters of ABR in the developmental age and in adults
.
Acta Otolaryngol
.
1988
;
105
(
5–6
):
587
90
. .
74.
Conti
G
,
Modica
V
,
Castrataro
A
,
Fileni
A
,
Colosimo
C
 Jr
.
Latency of the auditory brainstem response (ABR) and head size. Evidence of the relationship by means of radiographic data
.
Scand Audiol Suppl
.
1988
;
30
:
219
23
.
75.
Dempsey
JJ
,
Censoprano
E
,
Mazor
M
.
Relationship between head size and latency of the auditory brainstem response
.
Audiology
.
1986
;
25
(
4–5
):
258
62
. .
76.
Ponton
CW
,
Eggermont
JJ
,
Coupland
SG
,
Winkelaar
R
.
The relation between head size and auditory brain-stem response interpeak latency maturation
.
J Acoust Soc Am
.
1993
;
94
(
4
):
2149
58
. .
77.
Källén
K
.
Maternal smoking during pregnancy and infant head circumference at birth
.
Early Hum Dev
.
2000
;
58
(
3
):
197
204
. .
78.
Eldredge
L
,
Salamy
A
.
Functional auditory development in preterm and full term infants
.
Early Hum Dev
.
1996
;
45
(
3
):
215
28
. .
79.
Boone
RT
,
Bower
CM
,
Martin
PF
.
Failed newborn hearing screens as presentation for otitis media with effusion in the newborn population
.
Int J Pediatr Otorhinolaryngol
.
2005
;
69
(
3
):
393
7
. .
80.
Hunter
LL
,
Davey
CS
,
Kohtz
A
,
Daly
KA
.
Hearing screening and middle ear measures in American Indian infants and toddlers
.
Int J Pediatr Otorhinolaryngol
.
2007
;
71
(
9
):
1429
38
. .
81.
Kaytancı
E
,
Ozdamar
OI
,
Acar
GO
,
Tekin
M
.
Evaluation of transiently evoked otoacoustic emissions and auditory brainstem responses in patients with multiple sclerosis
.
Ear Nose Throat J
.
2016
;
95
(
10–11
):
E12
7
.
82.
Salamy
A
,
McKean
CM
.
Postnatal development of human brainstem potentials during the first year of life
.
Electroencephalogr Clin Neurophysiol
.
1976
;
40
(
4
):
418
26
. .
83.
Hecox
K
,
Burkard
R
.
Developmental dependencies of the human brainstem auditory evoked response
.
Ann N Y Acad Sci
.
1982
;
388
:
538
56
. .
84.
Møller
AR
,
Jannetta
PJ
.
Auditory evoked potentials recorded intracranially from the brain stem in man
.
Exp Neurol
.
1982
;
78
(
1
):
144
57
.
85.
Barazangi
N
,
Role
LW
.
Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala
.
J Neurophysiol
.
2001
;
86
(
1
):
463
74
. .
86.
Slotkin
TA
.
Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates
.
Toxicol Appl Pharmacol
.
2004
;
198
(
2
):
132
51
. .
87.
Fregosi
RF
,
Pilarski
JQ
.
Prenatal nicotine exposure and development of nicotinic and fast amino acid-mediated neurotransmission in the control of breathing
.
Respir Physiol Neurobiol
.
2008
;
164
(
1–2
):
80
6
. .
88.
Fuchs
PA
,
Lauer
AM
.
Efferent inhibition of the cochlea
.
Cold Spring Harb Perspect Med
.
2019
;
9
(
5
):
a033530
. .
89.
Simmons
DD
.
Development of the inner ear efferent system across vertebrate species
.
J Neurobiol
.
2002
;
53
(
2
):
228
50
. .
90.
Moore
JK
,
Linthicum
FH
 Jr
.
The human auditory system: a timeline of development
.
Int J Audiol
.
2007
;
46
(
9
):
460
78
. .
91.
Schrott-Fischer
A
,
Kammen-Jolly
K
,
Scholtz
A
,
Rask-Andersen
H
,
Glueckert
R
,
Eybalin
M
.
Efferent neurotransmitters in the human cochlea and vestibule
.
Acta Otolaryngol
.
2007
;
127
(
1
):
13
9
. .
92.
Raji-Kubba
J
,
Micevych
PE
,
Simmons
DD
.
The superior olivary complex of the hamster has multiple periods of cholinergic neuron development
.
J Chem Neuroanat
.
2002
;
24
(
2
):
75
93
. .
93.
Glowatzki
E
,
Fuchs
PA
.
Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea
.
Science
.
2000
;
288
(
5475
):
2366
8
. .
94.
Liberman
MC
,
Dodds
LW
,
Pierce
S
.
Afferent and efferent innervation of the cat cochlea: quantitative analysis with light and electron microscopy
.
J Comp Neurol
.
1990
;
301
(
3
):
443
60
. .
95.
Simmons
DD
,
Bertolotto
C
,
Kim
J
,
Raji-Kubba
J
,
Mansdorf
N
.
Choline acetyltransferase expression during a putative developmental waiting period
.
J Comp Neurol
.
1998
;
397
(
2
):
281
95
. .
96.
Simmons
DD
,
Mansdorf
NB
,
Kim
JH
.
Olivocochlear innervation of inner and outer hair cells during postnatal maturation: evidence for a waiting period
.
J Comp Neurol
.
1996
;
370
(
4
):
551
62
. .
97.
Simmons
DD
,
Manson-Gieseke
L
,
Hendrix
TW
,
McCarter
S
.
Reconstructions of efferent fibers in the postnatal hamster cochlea
.
Hear Res
.
1990
;
49
(
1–3
):
127
39
. .
98.
Katz
E
,
Elgoyhen
AB
,
Gómez-Casati
ME
,
Knipper
M
,
Vetter
DE
,
Fuchs
PA
,
Developmental regulation of nicotinic synapses on cochlear inner hair cells
.
J Neurosci
.
2004
;
24
(
36
):
7814
20
. .
99.
Roux
I
,
Wersinger
E
,
McIntosh
JM
,
Fuchs
PA
,
Glowatzki
E
.
Onset of cholinergic efferent synaptic function in sensory hair cells of the rat cochlea
.
J Neurosci
.
2011
;
31
(
42
):
15092
101
. .
100.
Vetter
DE
,
Liberman
MC
,
Mann
J
,
Barhanin
J
,
Boulter
J
,
Brown
MC
,
Role of alpha9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation
.
Neuron
.
1999
;
23
(
1
):
93
103
. .
101.
Murthy
V
,
Taranda
J
,
Elgoyhen
AB
,
Vetter
DE
.
Activity of nAChRs containing alpha9 subunits modulates synapse stabilization via bidirectional signaling programs
.
Dev Neurobiol
.
2009
;
69
(
14
):
931
49
. .
102.
Johnson
SL
,
Wedemeyer
C
,
Vetter
DE
,
Adachi
R
,
Holley
MC
,
Elgoyhen
AB
,
Cholinergic efferent synaptic transmission regulates the maturation of auditory hair cell ribbon synapses
.
Open Biol
.
2013
;
3
(
11
):
130163
. .
103.
Lavezzi
AM
.
Toxic effect of cigarette smoke on brainstem nicotinic receptor expression: primary cause of sudden unexplained perinatal death
.
Toxics
.
2018
;
6
(
4
):
63
. .
104.
Baumann
VJ
,
Koch
U
.
Perinatal nicotine exposure impairs the maturation of glutamatergic inputs in the auditory brainstem
.
J Physiol
.
2017
;
595
(
11
):
3573
90
. .
105.
Kervern
M
,
Dubois
C
,
Naassila
M
,
Daoust
M
,
Pierrefiche
O
.
Perinatal alcohol exposure in rat induces long-term depression of respiration after episodic hypoxia
.
Am J Respir Crit Care Med
.
2009
;
179
(
7
):
608
14
. .
106.
Gleason
CA
,
Iida
H
,
Hotchkiss
KJ
,
Northington
FJ
,
Traystman
RJ
.
Newborn cerebrovascular responses after first trimester moderate maternal ethanol exposure in sheep
.
Pediatr Res
.
1997
;
42
(
1
):
39
45
. .
107.
Mayock
DE
,
Ness
D
,
Mondares
RL
,
Gleason
CA
.
Binge alcohol exposure in the second trimester attenuates fetal cerebral blood flow response to hypoxia
.
J Appl Physiol
.
1985
;
102
(
3
):
972
7
. .2007
108.
Leite
JN
,
Silva
VS
,
Buzo
BC
.
Otoacoustic emissions in newborns with mild and moderate perinatal hypoxia
.
Codas
.
2016
;
28
(
2
):
93
8
. .
109.
Ikonomidou
C
,
Bittigau
P
,
Ishimaru
MJ
,
Wozniak
DF
,
Koch
C
,
Genz
K
,
Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome
.
Science
.
2000
;
287
(
5455
):
1056
60
. .
110.
Olney
JW
,
Ishimaru
MJ
,
Bittigau
P
,
Ikonomidou
C
.
Ethanol-induced apoptotic neurodegeneration in the developing brain
.
Apoptosis
.
2000
;
5
(
6
):
515
21
. .
111.
Toesca
A
,
Giannetti
S
,
Granato
A
.
Overexpression of the p75 neurotrophin receptor in the sensori-motor cortex of rats exposed to ethanol during early postnatal life
.
Neurosci Lett
.
2003
;
342
(
1–2
):
89
92
. .
112.
Olney
JW
,
Tenkova
T
,
Dikranian
K
,
Qin
YQ
,
Labruyere
J
,
Ikonomidou
C
.
Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain
.
Brain Res Dev Brain Res
.
2002
;
133
(
2
):
115
26
. .
113.
Kelly
JP
,
Wong
D
.
Laminar connections of the cat’s auditory cortex
.
Brain Res
.
1981
;
212
(
1
):
1
15
. .
114.
Gordon
HW
.
Hemispheric asymmetry of development due to drug exposure
.
J Syst Integr Neurosci
.
2017
;
3
(
3
):
10.15761/JSIN.1000162
. .
115.
Rajaprakash
M
,
Chakravarty
MM
,
Lerch
JP
,
Rovet
J
.
Cortical morphology in children with alcohol-related neurodevelopmental disorder
.
Brain Behav
.
2014
;
4
(
1
):
41
50
. .
116.
Lebel
C
,
Mattson
SN
,
Riley
EP
,
Jones
KL
,
Adnams
CM
,
May
PA
,
A longitudinal study of the long-term consequences of drinking during pregnancy: heavy in utero alcohol exposure disrupts the normal processes of brain development
.
J Neurosci
.
2012
;
32
(
44
):
15243
51
. .
117.
Sowell
ER
,
Thompson
PM
,
Peterson
BS
,
Mattson
SN
,
Welcome
SE
,
Henkenius
AL
,
Mapping cortical gray matter asymmetry patterns in adolescents with heavy prenatal alcohol exposure
.
NeuroImage
.
2002
;
17
(
4
):
1807
19
. .
118.
Watkins
KE
,
Paus
T
,
Lerch
JP
,
Zijdenbos
A
,
Collins
DL
,
Neelin
P
,
Structural asymmetries in the human brain: a voxel-based statistical analysis of 142 MRI scans
.
Cereb Cortex
.
2001
;
11
(
9
):
868
77
. .
119.
Terreros
G
,
Delano
PH
.
Corticofugal modulation of peripheral auditory responses
.
Front Syst Neurosci
.
2015
;
9
(
134
):
134
. .
120.
Collet
L
,
Kemp
DT
,
Veuillet
E
,
Duclaux
R
,
Moulin
A
,
Morgon
A
.
Effect of contralateral auditory stimuli on active cochlear micro-mechanical properties in human subjects
.
Hear Res
.
1990
;
43
(
2–3
):
251
61
. .
121.
Khalfa
S
,
Bougeard
R
,
Morand
N
,
Veuillet
E
,
Isnard
J
,
Guenot
M
,
Evidence of peripheral auditory activity modulation by the auditory cortex in humans
.
Neuroscience
.
2001
;
104
(
2
):
347
58
. .
122.
Perrot
X
,
Ryvlin
P
,
Isnard
J
,
Guénot
M
,
Catenoix
H
,
Fischer
C
,
Evidence for corticofugal modulation of peripheral auditory activity in humans
.
Cereb Cortex
.
2006
;
16
(
7
):
941
8
. .
123.
He
DZ
.
Relationship between the development of outer hair cell electromotility and efferent innervation: a study in cultured organ of corti of neonatal gerbils
.
J Neurosci
.
1997
;
17
(
10
):
3634
43
. .
124.
Kujawa
SG
,
Liberman
MC
.
Conditioning-related protection from acoustic injury: effects of chronic deefferentation and sham surgery
.
J Neurophysiol
.
1997
;
78
(
6
):
3095
106
. .
125.
Liberman
MC
,
Liberman
LD
,
Maison
SF
.
Efferent feedback slows cochlear aging
.
J Neurosci
.
2014
;
34
(
13
):
4599
607
. .
126.
Bennetto
L
,
Keith
JM
,
Allen
PD
,
Luebke
AE
.
Children with autism spectrum disorder have reduced otoacoustic emissions at the 1 kHz mid-frequency region
.
Autism Res
.
2017
;
10
(
2
):
337
45
. .
127.
Miron
O
,
Beam
AL
,
Kohane
IS
.
Auditory brainstem response in infants and children with autism spectrum disorder: a meta-analysis of wave V
.
Autism Res
.
2018
;
11
(
2
):
355
63
. .
128.
Ramezani
M
,
Lotfi
Y
,
Moossavi
A
,
Bakhshi
E
.
Auditory brainstem response to speech in children with high functional autism spectrum disorder
.
Neurol Sci
.
2019
;
40
(
1
):
121
5
. .
129.
Santos
M
,
Marques
C
,
Nóbrega Pinto
A
,
Fernandes
R
,
Coutinho
MB
,
Almeida E Sousa
C
.
Autism spectrum disorders and the amplitude of auditory brainstem response wave I
.
Autism Res
.
2017
;
10
(
7
):
1300
5
. .
130.
Wilson
US
,
Sadler
KM
,
Hancock
KE
,
Guinan
JJ
 Jr
,
Lichtenhan
JT
.
Efferent inhibition strength is a physiological correlate of hyperacusis in children with autism spectrum disorder
.
J Neurophysiol
.
2017
;
118
(
2
):
1164
72
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.